Fibromyalgia Relief Tablet, Orally Disintegrating
FDA Label NDC 17312-171

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Trp Company for the product Fibromyalgia Relief (NDC 17312-171). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, uses, otc - pregnancy or breast feeding, directions, other information, inactive ingredients, do not use if tamper evident seal is torn, broken or missing., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Active Ingredient

Bryonia HPUS 6C, 12C, 18C
Causticum HPUS 6C, 12C, 18C
Hoitzia HPUS 6C, 12C, 18C
Magnesia phosphorica HPUS 6C,12C,18C
Pulsatilla HPUS 6C,12C,18C
Rhus tox HPUS 6C,12C,18C
Valeriana officinalis HPUS 6C,12C,18C

HPUS indicates the active ingredients are in the Homeopathic Pharmacopoeia of the United States.

Otc - Purpose

Bryonia HPUS............................Difficulty moving, Stiff joints, acute soreness
Causticum HPUS.......................Muscle and nerve soreness
Hoitzia HPUS.............................Chronic discomfort, fatigue
Magnesia phosphorica HPUS ...Cramping, Fatigue
Pulsatilla HPUS .........................Migrating soreness
Rhus tox HPUS..........................Soft tissue discomfort
Valeriana officinalis HPUS..........Sleeplessness, Irritable bowels

Uses

• According to homeopathic indications these ingredients provide temporary relief from symptoms such as: • Muscle soreness • Fatigue • Nerve / soft tissue tenderness • Multiple tender points; after serious causes have been ruled out by a physician. * These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.

* Please review the disclaimer below.